<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01497405</url>
  </required_header>
  <id_info>
    <org_study_id>1R01DA032061-01</org_study_id>
    <nct_id>NCT01497405</nct_id>
  </id_info>
  <brief_title>WHC+ (Women's Health CoOp PLUS)</brief_title>
  <official_title>Combination Prevention for Vulnerable Women in South Africa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RTI International</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RTI International</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares the effects of standard HIV test, treat and retain (TTR) practices with
      TTR plus a woman-focused enhanced strategy--Women's Health CoOp (WHC+) intervention)
      targeting hard-to-reach and vulnerable alcohol and other drug (AOD)-using women to determine
      if the WHC+ intervention is more efficacious than TTR alone in reducing HIV risk behavior.
      Additionally, the study will determine whether HIV positive women in the WHC+ arm are more
      likely to follow through with referrals for further medical evaluation and linkages to HIV
      treatment and other care than women in the TTR arm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There is growing recognition that no single strategy will be sufficient to eliminate
      transmission. In light of evidence that neither existing biomedical interventions nor any
      existing behavioral interventions will be sufficient to control the HIV epidemic in South
      Africa, the proposed study will combine a biomedical intervention with an evidence-based
      behavioral intervention (i.e., the Women's Health CoOp) to maximize the efficacy of both
      strategies. If this combination intervention proves efficacious, there is a high likelihood
      that it can be widely implemented, be sustainable and have a substantial public health impact
      by reducing the exceedingly high HIV incidence in South Africa.

      The overarching goal of the proposed research is to determine whether this enhanced
      combination prevention strategy targeting vulnerable AOD-using women is more efficacious than
      current standard practices. The specific aims of the proposed study are:

      Aim 1: To expand the WHC outreach strategies to reach more alcohol and other drug (AOD) -
      using vulnerable women in Pretoria, South Africa.

      Aim 2: To test whether adding WHC to standard Treat, Test, and Retain (TTR) practices results
      in more HIV-positive AOD-using women getting medical evaluations (e.g., cluster of
      differentiation 4 (CD4), viral load), starting treatment, staying in treatment and in greater
      reductions in risk behaviors (e.g., AOD use, condom use, victimization) among all
      women-positive or negative.

      The study uses a geographical cluster randomized design. Hotspots (i.e. places where sex
      workers and drug using women congregate) in the city of Pretoria and the surrounding areas
      were mapped using geographic information system (GIS) software. Fourteen hotspots were
      identified and geocoded. The entire area was divided into 14 zones, each of which included a
      hotspot. Seven matched pairs of zones were created based on socio-economic conditions and
      estimates of the numbers of sex workers and drug-using women residing in them. Zones within
      pairs were randomized to the TTR arm or the WHC+ arm. Participants are recruited by outreach
      workers and their intervention condition is based on the zone from which they were recruited.
      At study enrollment/baseline, eligible participants complete a questionnaire and baseline
      HIV, drug and pregnancy testing. Follow-up data collection will be conducted at 6-months and
      12-months post-baseline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Unprotected intercourse among women</measure>
    <time_frame>6 months</time_frame>
    <description>Percentages of condom use at last sex</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Unprotected intercourse among women</measure>
    <time_frame>12 months</time_frame>
    <description>Percentages of condom use at last sex</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medical evaluation initiation amongst HIV-positive</measure>
    <time_frame>6 months</time_frame>
    <description>Percentages of HIV-positive women receiving medical evaluations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical evaluation initiation amongst HIV-positive</measure>
    <time_frame>12 months</time_frame>
    <description>Percentages of HIV-positive women receiving medical evaluations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment initiation and retention amongst HIV-positive women</measure>
    <time_frame>6 months</time_frame>
    <description>Percentages of HIV-positive women starting and staying in treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment initiation and retention amongst HIV-positive women</measure>
    <time_frame>12 months</time_frame>
    <description>Percentages of HIV-positive women starting and staying in treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV viral load among HIV-positive women who meet criteria for antiretroviral treatment (ART) and who produce medical records with HIV viral loads</measure>
    <time_frame>6 months</time_frame>
    <description>HIV viral load from medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV viral load among HIV-positive women who meet criteria for antiretroviral treatment (ART) and who produce medical records with HIV viral loads</measure>
    <time_frame>12 months</time_frame>
    <description>HIV viral load from medical record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol use</measure>
    <time_frame>6 months post intervention</time_frame>
    <description>Frequency of alcohol use in previous 30 days measured by Revised Risk Behavior Assessment (RRBA) and breath test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol use</measure>
    <time_frame>12 months post intervention</time_frame>
    <description>Frequency of alcohol use in previous 30 days measured by Revised Risk Behavior Assessment (RRBA) and breath test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Victimization</measure>
    <time_frame>6 months post intervention</time_frame>
    <description>Percentages of women who report being beaten, attacked with a weapon, or forced to have sex in the previous 90 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Victimization</measure>
    <time_frame>12 months post intervention</time_frame>
    <description>Percentages of women who report being beaten, attacked with a weapon, or forced to have sex in the previous 90 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">641</enrollment>
  <condition>HIV</condition>
  <condition>Sexual Risk</condition>
  <condition>Sexually Transmitted Diseases</condition>
  <condition>Substance Abuse</condition>
  <condition>Violence</condition>
  <condition>Victimization</condition>
  <arm_group>
    <arm_group_label>Test, Treat, Retain(TTR) only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group will be screened for HIV. HIV positive women will be given post-test counseling and referrals for prompt medical evaluation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test, Treat, Retain(TTR) + Women's Health CoOp (WHC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TTR +WHC: Participants in this group will be screened for HIV. HIV positive women, will be given post-test counseling and referrals for prompt medical evaluation and assessment. Both HIV negative and positive participants in this group will participate in 2 individual behavioral counseling sessions focusing on reducing HIV risk behaviours, alcohol and other drug use, and risk of violent victimization. It also adds case management to increase follow through with referrals and risk reduction plans and activities. This intervention is an adaptation of the evidence-based Women's CoOp(PI: Dr. Wendee M. Wechsberg).</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Test, Treat, Retain(TTR) + Women's Health CoOp (WHC)</intervention_name>
    <description>TTR +WHC: Participants in this group will be screened for HIV. HIV positive women, will be given post-test counseling and referrals for prompt medical evaluation and assessment.Both HIV negative and positive participants in this group will participate in 2 individual behavioral counseling sessions focusing on reducing HIV risk behaviours, alcohol and other drug use, and risk of violent victimization. It also adds case management to increase follow through with referrals and risk reduction plans and activities.This will also include case management sessions. This intervention is an adaptation of the evidence-based Women's CoOp (PI: Dr. Wendee M. Wechsberg).</description>
    <arm_group_label>Test, Treat, Retain(TTR) + Women's Health CoOp (WHC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Test, Treat, Retain(TTR) only</intervention_name>
    <description>TTR +only: Participants in this group will be screened for HIV. HIV positive women will be given post-test counseling and referrals for prompt medical evaluation.</description>
    <arm_group_label>Test, Treat, Retain(TTR) only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female

          2. Black/African

          3. 15 years or older (if under 18, must be able to sign assent)

          4. Use at least one of the following drugs: alcohol, marijuana (dagga), methamphetamine
             (tik), Mandrax (methaqualone), cocaine (crack and/or powder), heroin (Thai White),
             inhalants (glue and benzene) methylenedioxymethamphetamine (MDMA -ecstasy), lysergic
             acid diethylamide (LSD), or Kat/cat, Nyaope (a mixture of marijuana and heroin) â€”
             weekly in the past 90 days

          5. Have had unprotected vaginal sex with a male partner in the last six months

          6. Able to speak English, Sesotho, Tswana, or Zulu

          7. Consent to HIV rapid testing and drug testing

          8. Provide written verbal and assent/consent to participate

          9. Able to provide verifiable locator information for the Tshwane area and plan to stay
             there in the next 12 months

        Exclusion Criteria:

          1. Males

          2. Individuals who do not self-identify as Black/African
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wendee M Wechsberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RTI International</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>RTI International - Headquarters</name>
      <address>
        <city>Research Triangle Park</city>
        <state>North Carolina</state>
        <zip>27709</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wesley Community Centre</name>
      <address>
        <city>Pretoria</city>
        <zip>0126</zip>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>South Africa</country>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Wechsberg WM, Deren S, Myers B, Kirtadze I, Zule WA, Howard B, El-Bassel N. Gender-Specific HIV Prevention Interventions for Women Who Use Alcohol and Other Drugs: The Evolution of the Science and Future Directions. J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S128-39. doi: 10.1097/QAI.0000000000000627.</citation>
    <PMID>25978479</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2011</study_first_submitted>
  <study_first_submitted_qc>December 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2011</study_first_posted>
  <last_update_submitted>September 18, 2017</last_update_submitted>
  <last_update_submitted_qc>September 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gender-based Violence</keyword>
  <keyword>HIV</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Sexually Transmitted Diseases</keyword>
  <keyword>Substance Abuse Detection</keyword>
  <keyword>Test, Treat and Retain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Sexually Transmitted Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

